ACADEMIC PUBLICATION

PUBLICATIONS

→ Benoit C & Gorry P*, (2017), Health Technology Assessment: The Scientific Career of a Policy Concept, International J. Technology Assessment in Health Care, 33, 128-134.

→ Smith A., (2017), The Economic Driven by Politics as Values: The Example of Pharmaceuticals in France. New Political Economy. 22, 611-627.

→ Benoit C & Nogues E., (2018), De l’administration des prix à la régulation du marché : enjeux et modalités de la fixation des prix des médicaments en France depuis 1948., Revue Française des Affaires Sociales, 3, 91-109.

WORKING PAPER

→ Gorry P* & Useche D., (2017), Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021. 

BOOKS AND BOOK CHAPTERS

→ Garden H., Paris V. & Gorry P. Pull Incentives for medical needs. OECD (eds), Science, Technology and Innovation Outlook 2016, Paris (France), OECD Publishing, 2016.

→ Gorry P* & Useche D. Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. in Ernst Berndt, Dana Goldman, and John Rowe (eds), Economic Dimensions of Personalized and Precision Medicine, University of Chicago Press, 2019.

Publishing, 2016.

→ Benoit C. Réguler l’accès aux médicaments, Presses Universitaires de Grenoble, 2020.

CONFERENCE PROCEDINGS

→ Faut-il de nouveaux modèles économiques ou financement pour accélérer le développement de nouveaux traitements des maladies rares (2014), Médecine/Sciences, 30 (HS n°1), 47-53.

SELECTED ORAL COMMUNICATIONS

→ Useche D, Gorry P, Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies, DRUID Society Conf., Copenhague, June 13-15, 2016.

→ Gorry P, Serendipity and university technology transfer: a case study. XXVII Int. Soc. Prof. Innovation Management Conference, Porto, June 19-22, 2016

→ Gorry P, Useche D, Zumpe M, Empirical economic analysis of orphan drug legislation impact on innovation, Eur. Health Economic Association Conf., Hamburg, July 13-16, 2016.

→ Benoit C, Gorry P, How does regulation affect beliefs? The case of Stock Market Valuation of  Orphan Drug Approval. Am. Political Sciences Asso. Conference, Philadelphia, Sept.1-4, 2016.

→ Gorry P, Pharma Competitive Intelligence using open source data and visualization tool: towards metrics for drug R&D milestones, 6th Global tech Mining Conf., Valencia, Sept. 13, 2016.

→ Gorry P, Useche D, Zumpe M, Empirical Economic Analysis of Orphan Drug Innovation, NBER Economic Dimensions of Personalized and Precision Medicine, Columbia Univ. NY, Sept 21-22, 2016.

→ Benoit C & Gorry P, Orphan Drugs: Why the US legislation approves more than the EU?, International Health Policy Conference, London School of Economics, Feb. 17-19, 2017.

→ Gorry P, Orphan Drug legislation: evaluation of the impact of market exclusivity extension, 12th International Health Economics Congress, Boston, July 8-11, 2017.

→ Benoit C, Gorry P, Useche D, Zumpe M, Empirical Economic Analysis of Orphan Drug Innovation, NBER Economic Dimensions of Personalized and Precision Medicine, Santa Monica. CA, Sept 13-14, 2017.

→ Gorry P, Lortal B & Breilh D. Evolution des prescriptions de médicaments orphelins en cancérologie : en France, et à l’échelle d’un établissement hospitalier. 30e Journées des Economistes de la Santé Français, Marseille, Nov. 30-Dec. 1, 2017.

→ Gorry P, Orphan Drug Market Exclusivity Extension versus Patent Monopoly. 7th Annual Conference of the American Society of Health Economists, Atlanta, June 10-13, 2018.

→ Gorry P. Does Orphan Drug market exclusivity incentive sustains drug development for rare diseases ? 12th European Conference on Health Economics, Maastricht, (NL), July11-14 , 2018.

→ Kourouklis D. & Gorry P, Market Valuation of FDA Orphan Drug Regulatory Events, 12th International Health Economics Congress, Basel, July 8-11, 2019.

→ Gorry P & Kourouklis D, R&D incentives and innovation spillovers: evidence from the European orphan drug regulation. 8th Biennial Atlanta Conf. on Science & Innovation Policy, Atlanta, Oct. 14-16, 2019.

SELECTED POSTERS

→ Useche D & Gorry P, “Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies”, 65th Annual Meeting of the French Economic Association, Nancy, June 27-29, 2015.

→ Gorry P, Lortal B, Breilh D, Evolution des prescriptions de médicaments orphelins en cancérologie: en France et à l’échelle d’un établissement hospitalier. 12e Journée du Cancéropôle Grand Sud-Ouest, La Grande-Motte, Nov. 23-25, 2016.

→ Gorry P,  & Bikfalvi A. Angiogenesis inhibitors drug pipeline landscape, 7ème Congrès de la Société Française d’Angiogénèse, Toulouse, April 23- 25, 2017.

→ Gorry P & Kouriklis D, Impact de la législation européenne des médicaments orphelins sur le marché global du médicament, RARE Rencontres des Maladies Rares, Paris, Nov. 4-5, 2019.

→ Gorry P & Useche D, Le statut de médicament orphelin est un signal positif pour les investisseurs lors de l’introduction en bourse des sociétés de biotechnologie, RARE Rencontres des Maladies Rares, Paris, Nov. 4-5, 2019.

→ Gorry P, Médicaments orphelins et maladies rares sur Twitter, RARE Rencontres des Maladies Rares, Paris, Nov. 4-5, 2019.

INVITED CONFERENCES

→ « Cancers rares & médicaments orphelins: quels médicaments innovants à quels prix ? » Séminaire CERMES, Paris, 18 Juin 2015.

→ « Economic analysis of the Orphan Drug market », Conférence Hospinnomics, AP-HP, Paris, 18 Nov., 2015.

→«Economic analysis of the Orphan Drug market », ELS seminar, OECD, Paris, Jan. 26, 2016.

→ « Impact économique de la dynamique du marché des médicaments orphelins : exemple des anticancéreux », Atelier Hospinnomics, AP-HP, Paris, 25 Janvier, 2016.

→ “Economic dimensions of Precision Medicine in Oncology”, Lake Como School of Advanced Studies on Cancer Development & Complexity, Como (IT), May 24-27, 2017.

→ « Analyse économique empirique de l’impact de la législation  sur les médicaments orphelins  en matière d’innovation », 5ème séminaire Innovation du LEDi « Jinnov » Univ.de Bourgogne, Dijon, 25 Juin 2018.

→ « Access to therapeutic innovations in Europe », Les journées Franco-Internationales d’Oncologie IFODS 2019, Paris, 13 juin 2019.

OTHER PARTICIPATIONS: CHAIRMAN, ROUND TABLES, ...

→ Discutant: 9th Annual Searle Center Conf. on Innovation Economics, Northwestern University School of Law Chicago, June 23-24, 2016.

→  Table ronde, modérateur: Les réseaux de cancérologie, 12e Journées du Cancéropole, Grand Sud-Ouest, Montpellier, 23-25 Nov. 2016.

→  Table Ronde: « Le cancer, de la recherche à la prise en charge du patient », Roadshow Cancer Nouvelle-Aquitaine, 13 Dec. 2017.